Irinotecan Hydrochloride contains not less than 98.0% and not more than 102.0% of C33H38N4O6‧HCl, calculated on anhydrous substance.

共有 1 個藥物證書使用此成份

鹽酸愛萊諾迪肯
Irinotecan Hydrochloride

• 申請商: 龍大生技股份有限公司
• 適應症: 抗癌藥
• 發證日期: 2014-07-24